Atlas Trials

Cannabidiol Oral Solution for the Treatment of Patients With Prader-Willi Syndrome

Clinical trial NCT02844933 · TERMINATED

Trial details

NCT number
NCT02844933
Sponsor
Radius Pharmaceuticals, Inc.
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Prader-Willi Syndrome
Start date
2018-05-09
Primary completion
2019-07-17
Enrollment
7

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.